Intended Use Study of the BD SurePath Plus™ Pap

NCT01234480 · clinicaltrials.gov ↗

TERMINATED

Status

5859

Enrollment

INDUSTRY

Sponsor class

Stopped Decided not to pursue commercialization of the product

Conditions

Uterine Cervical Neoplasms
Uterine Cervical Cancer
Neoplasms, Squamous Cell
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Papilloma

Interventions

DEVICE: BD SurePath Plus Pap test
DEVICE: BD SurePath Pap test
PROCEDURE: colposcopy with biopsy/ECC
DEVICE: HPV DNA test

Sponsor

Becton, Dickinson and Company